Picture of ProMIS Neurosciences logo

PMN — ProMIS Neurosciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Brief: ProMIS Neurosciences Strengthens Board with Appointment of Slanix Paul Alex, Pharm.D., President and Portfolio Manager, Public Equity of Ally Bridge Group

Oct 22 (Reuters) - ProMIS Neurosciences Inc PMN.O:

PROMIS NEUROSCIENCES STRENGTHENS BOARD WITH APPOINTMENT OF SLANIX PAUL ALEX, PHARM.D., PRESIDENT AND PORTFOLIO MANAGER, PUBLIC EQUITY OF ALLY BRIDGE GROUP

Source text: ID:nGNX4wvG4f

Further company coverage: PMN.O

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on ProMIS Neurosciences

See all news